Search Results

View the sub-population slides on Lesbian, Gay, & Bisexual (LGB) Adults based on the graphics, tables, and figures from the 2019 NSDUH Annual Report.

The National Directory of Mental Health Treatment Facilities - 2020 is a listing of federal, state, and local government facilities and private facilities that provide mental health treatment services. It includes treatment facilities that responded to the 2019 National Mental Health Services Survey (N-MHSS). The information about each facility that...

View the sub-population slides on Lesbian, Gay, & Bisexual (LGB) Adults based on the graphics, tables, and figures from the 2018 NSDUH Annual Report.

The National Directory of Mental Health Treatment Facilities - 2019 is a listing of federal, state, and local government facilities and private facilities that provide mental health treatment services. It includes treatment facilities that responded to the 2018 National Mental Health Services Survey (N-MHSS). The information about each facility that...

These summary sheets are 2015 and 2016 NSDUH estimates such as binge drinking, illicit drug use, and treatment use for bisexual, lesbian/gay, and sexual minorities.

This short report uses data from the Drug Abuse Warning Network (DAWN) to examine the emergency department (ED) visits for children aged 1 -5 that involved opioid pain relievers. Hydrocodone (Vicodin, Lortab), oxycodone (OxyContin, Percocet), and codeine are examples of opioid pain relievers; buprenorphine (Suboxone), is an opioid that is...

This report summarizes methods and other supporting information that are relevant to estimates of substance use and mental health issues from the 2016 National Survey on Drug Use and Health (NSDUH), an annual survey of the civilian, noninstitutionalized population of the United States aged 12 years old or older. NSDUH...

This report presents estimates for substance use and mental health from the 2015 National Survey on Drug Use and Health (NSDUH) for adults aged 18 or older based on respondent sexual identity characteristics. Comparisons are made for sexual minority and sexual majority members among all adults and by sex and...

This report summarizes methods and other supporting information that are relevant to estimates of substance use and mental health issues from the 2015 National Survey on Drug Use and Health (NSDUH), an annual survey of the civilian, noninstitutionalized population of the United States aged 12 years old or older. Section...

The purpose of this report is to describe the differences between the DSM-IV and DSM-5 diagnostic criteria that could affect national estimates of childhood serious emotional disturbance (SED). The report also provides a description of DSM-5 updates
that have been made (or are being made) to existing diagnostic instruments and...

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables. The URS is a state, national, and territories reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization...

This short report uses data on drug-related emergency department (ED) visits from the Drug Abuse Warning Network to examine the trends in ED visits involving methamphetamine from 2007 to 2011. In addition to the trends for total methamphetamine-related visits, it also shows trends by gender and by age group; the...

Excel file with national estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits, covering 2004-2011. File includes all drug-related ED visits that are reportable to DAWN without regard for the reason for the visit or the specific drugs involved. It includes visits involving...

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving attention deficit/hyperactivity disorder stimulant medications between 2005 and 2010. The report shows visits for nonmedical use, adverse reactions, visits involving other pharmaceuticals, illicit drugs or alcohol.